Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Nurs Clin North Am ; 58(2): 165-181, 2023 06.
Article in English | MEDLINE | ID: mdl-37105652

ABSTRACT

In the United States, the opioid epidemic and COVID-19-related substance use have exacerbated the overall incidence of substance use disorders (SUDs). Medication-assisted therapy (MAT), or cognitive and behavioral therapy that combines medications that reduce substance use or acute withdrawal symptoms, has dramatically improved outcomes for SUD patients, including preventing mortality. With recent US Congressional funding for MAT, patients presenting for acute care on MAT-related medications will continue to increase. Nurses should be aware of these medications' mechanism of action, typical side effects, and implications on treating acute pain to optimize their care.


Subject(s)
COVID-19 , Opioid-Related Disorders , Substance-Related Disorders , Humans , United States , Behavior Therapy , Opioid-Related Disorders/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...